0001209191-20-044578.txt : 20200804 0001209191-20-044578.hdr.sgml : 20200804 20200804083510 ACCESSION NUMBER: 0001209191-20-044578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200801 FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOYER ANDREW S CENTRAL INDEX KEY: 0001239546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 201071049 MAIL ADDRESS: STREET 1: C/O WATSON PHARMA INC STREET 2: 360 MOUNT KEMBLE AVE CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-01 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001239546 BOYER ANDREW S C/O AMNEAL PHARMACEUTICALS, INC. BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President Class A Common Stock 109933 D Restricted Stock Units 2020-08-01 4 A 0 69284 0.00 A Class A Common Stock 69284 102595 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. The restricted stock units vest in three equal annual installments beginning on June 30, 2021. /s/ Meredith Cook, Attorney-in-Fact 2020-08-04